Jeppson Wealth Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDTX
RCM
HI
DGM
VC
JFG
Jeppson Wealth Management's CDTX Position: Q4 2025 in Review
Jeppson Wealth Management sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 6,155 shares — an estimated $589K sold.
Jeppson Wealth Management first reported a position in CDTX in Q3 2020 and held it in 17 quarters. The position peaked at $589K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.
- Jeppson Wealth Management reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
- Jeppson Wealth Management sold 6,155 Cidara Therapeutics shares in Q4 2025, an estimated $589K.
- Jeppson Wealth Management first reported a position in Cidara Therapeutics in Q3 2020 and held it in 17 quarters.
- Jeppson Wealth Management's Cidara Therapeutics position peaked at $589K in Q3 2025.
- 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.
Based on Jeppson Wealth Management's 13F filing for Q4 2025, filed 27 Jan 2026.